Compassionate Access: No Good Answer

George Annas, School of Public Health

Here’s a very good look (via the New York Times magazine) at the area of “compassionate use” medications – the practice of allowing desperate patients access to an investigational drug long before it’s approved by the FDA…

Expert quote:

“Even if patients with cancer are willing buyers, drug manufacturers are not willing sellers.”

View full article